放射学轴性脊柱关节炎患者低剂量CT两年随访中韧带骨赘与小关节强直的关联
本研究纳入51例放射学轴性脊柱关节炎(r-axSpA)患者,在基线和2年时进行全脊柱低剂量CT(ldCT)和MRI检查,评估韧带骨赘与小关节强直(FJA)是否互相增加发生风险。结果显示,基线桥接韧带骨赘与随后FJA发生的OR为3.55(95%CI 2.03,6.21)和3.30(95%CI 2.14,5.09);基线FJA与新发韧带骨赘的OR为1.87(95%CI 1.20,2.92)和1.69(95%CI 0.88,3.22)。作者结论为椎体与小关节的骨形成互相影响,韧带骨赘的作用大于FJA。
要点
- 基线桥接韧带骨赘对2年后同一椎体单元FJA发生的OR为3.55(95%CI 2.03,6.21)和3.30(95%CI 2.14,5.09)。
- 基线FJA对2年后同一椎体单元新发韧带骨赘的OR为1.87(95%CI 1.20,2.92)和1.69(95%CI 0.88,3.22)。
- 作者结论为椎体与小关节骨形成互相影响,韧带骨赘的作用大于FJA。
核心结论
- 椎体骨形成与小关节骨形成互相影响对方的出现,韧带骨赘的作用大于FJA。
研究设计与样本
- 放射学轴性脊柱关节炎(r-axSpA)患者51例,基线及2年时行全脊柱低剂量CT(ldCT)和MRI检查;ldCT评估椎体韧带骨赘的存在与大小及小关节强直,MRI评估炎症。
- 采用广义估计方程模型检验两个假设,模型A以FJA/韧带骨赘增加为结局,模型B以FJA/韧带骨赘存在为结局,均校正基线炎症;次要分析检验相邻椎体单元结局及剂量-反应效应。
主要发现
- 患者平均年龄49岁,84%为男性,82%为HLA-B27阳性。
- 基线桥接韧带骨赘较FJA更常见,各椎体单元范围为10-60% vs 8-36%。
- 基线桥接韧带骨赘对FJA发生的OR:模型A为3.55(95%CI 2.03,6.21),模型B为3.30(95%CI 2.14,5.09)。
- 基线FJA对新发韧带骨赘的OR:模型A为1.87(95%CI 1.20,2.92),模型B为1.69(95%CI 0.88,3.22)。
- 次要分析中两个假设均得到阳性OR。
关键数值与推荐
- 基线桥接韧带骨赘对2年后同一椎体单元FJA发生的OR为3.55(95%CI 2.03,6.21)(模型A)和3.30(95%CI 2.14,5.09)(模型B)。
- 基线FJA对2年后同一椎体单元新发韧带骨赘的OR为1.87(95%CI 1.20,2.92)(模型A)和1.69(95%CI 0.88,3.22)(模型B)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In radiographic axial spondyloarthritis (r-axSpA), spinal damage manifests as syndesmophytes and facet joint ankylosis (FJA). We evaluated whether the presence of one lesion increased the risk of the other lesion. METHODS: Patients with r-axSpA underwent low-dose CT (ldCT) and MRI of the whole spine at baseline and 2 years. On ldCT, vertebrae were scored for presence and size of syndesmophytes; facet joints were assessed for ankylosis. MR images were assessed for inflammation. Two hypotheses were tested: (i) presence of FJA is associated with new syndesmophyte(s) on the same vertebral unit (VU) 2 years later, and (ii) presence of bridging syndesmophyte(s) is associated with new FJA on the same VU 2 years later. Two generalized estimating equations models were tested per hypothesis using increase of FJA/syndesmophytes (model A) or presence of FJA/syndesmophytes (model B) as outcome, adjusted for inflammation at baseline. Secondary analyses tested the hypotheses with outcomes on adjacent VUs and dose-response effects. RESULTS: Fifty-one patients were included (mean age 49, 84% male, 82% HLA-B27+). Baseline bridging syndesmophytes occurred more often (range: 10-60% per VU) than FJA (range: 8-36%). Odds ratios (ORs) (95% CI) for presence of bridging syndesmophytes on development of FJA were 3.55 (2.03, 6.21) for model A and 3.30 (2.14, 5.09) for model B. ORs for presence of baseline FJA on new syndesmophytes were 1.87 (1.20, 2.92) for model A and 1.69 (0.88, 3.22) for model B. Secondary analyses yielded positive ORs for both hypotheses. CONCLUSIONS: Bone formation in vertebrae and in facet joints influence each other's occurrence, with the effect of syndesmophytes being larger than that of FJA.
引用
- Stal R, Sepriano A, van Gaalen FA, et al. Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. Rheumatology (Oxford). 2022. PMID: 35302592. doi:10.1093/rheumatology/keac176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。